Columns
Novartis and Health – An analysis by Rajeev Dhavan
The Novartis judgment has started a huge war of words. The patent drug producers are livid. They declare: “Woe is us. This is the end of invention.” The generic drug makers say: “Well done Supreme Court. Now we can supply life saving drugs to India and the world at cheaper prices.”